Ottawa, Canada, March 19, 2020 (GLOBE NEWSWIRE) — Orion Biotechnology Canada Ltd., a clinical stage biotechnology company, today announced that it will be presenting an update on the company’s development program at the BIO-Europe Spring
Ottawa, Canada, Feb. 06, 2020 (GLOBE NEWSWIRE) — Orion Biotechnology Canada Ltd., a clinical-stage company, today announced the addition of Dr. Andreas Harstrick to its Scientific Advisory Board (SAB). Dr. Harstrick brings extensive experience in global
Ottawa, Canada, Jan. 21, 2020 (GLOBE NEWSWIRE) — Orion Biotechnology Canada Ltd., a clinical stage biotechnology company, today announced that it has executed a definitive agreement with the University of Geneva for an exclusive global
OTTAWA, Ontario, November 12, 2019 (Newswire.com) – Orion Biotechnology Canada Ltd. today announced that Dr. Thomas Hecht has been appointed Chairman of its Board of Directors. Dr. Hecht brings extensive expertise in leading value creation processes
OTTAWA, Ontario, October 31, 2019 (Newswire.com) – Orion Biotechnology Canada, Ltd. today announced that OB-002 was able to significantly reduce bone metastasis in a murine model of breast cancer. The study was conducted in collaboration with
OTTAWA, Canada, August 6, 2019 (Newswire.com) – Orion Biotechnology Canada Ltd. today announced that Sir Gregory Winter FRS has agreed to chair the Orion Biotechnology Scientific Advisory Board (SAB). Sir Gregory Winter FRS is a
343 Preston Street
11th floor,
Ottawa, On K1S 1N4
CANADA
+1 343.291.1032
Campus Biotech
Innovation Park
Avenue de Sécheron 15
1202 Genève
SWITZERLAND
Orion Biotechnology
Life Science Park
UI Bobrzyńskiego 14
30-348 Krakôw
POLAND
Leave us a message and we will try to respond by the next business day
343 Preston Street
11th floor,
Ottawa, ON K1S 1N4
CANADA
info@orionbiotechnology.com
+1 343.291.1032
Leave us a message and we will try to respond by the next business day
343 Preston Street
11th floor,
Ottawa, ON K1S 1N4
CANADA
info@orionbiotechnology.com
+1 343.291.1032
